T1D is a chronic disease characterized by autoimmune destruction of insulin-producing β cells in the pancreas1, affecting 8.4 million individuals worldwide in 2021, with an estimated to increase to 13.5–17.4 million by 20402. The gene discussed is INS; the disease is type 1 diabetes mellitus.